Regenxbio (RGNX) Share-based Compensation (2014 - 2026)
Regenxbio (RGNX) reported Share-based Compensation of $9.05 million for Q2 2026, up 4.6% from $8.65 million a year earlier and up 5.1% from the prior quarter.
Powered by 
Analysis
Regenxbio (RGNX) Share-based Compensation (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Regenxbio's Share-based Compensation came in at $35.04 million, down 4.3% year-over-year; for FY2025, it came in at $34.56 million, down 10.1% from FY2024.
- Share-based Compensation has declined for three consecutive years, though with a five-year compound annual growth rate of 1.6% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $38.46 million in FY2024 (-4.5%), $40.27 million in FY2023 (-1.3%), $40.79 million in FY2022 (+5.1%) and $38.81 million in FY2021 (+21.5%).
- The Q2 2026 figure ranks as the highest quarterly Share-based Compensation since Q4 2024.
- Year over year, Share-based Compensation gained in three of the last eight quarters, with an average decline of 3.0%.
- The high point for year-over-year Share-based Compensation in five years was Q3 2021 (growth of 21.1%); the low point was Q1 2024 (a decline of 14.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $8.62 million (Q1 2026), $8.38 million (Q4 2025) and $9 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Regenxbio | 508.48 Mn | -228.57 Mn | - | 8.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 8.12 Mn |
| Jun 30, 2026 | 9.05 Mn |
| Mar 31, 2026 | 8.62 Mn |
| Dec 31, 2025 | 8.38 Mn |
| Sep 30, 2025 | 9.00 Mn |
| Jun 30, 2025 | 8.65 Mn |
| Mar 31, 2025 | 8.54 Mn |
| Dec 31, 2024 | 9.54 Mn |
| Sep 30, 2024 | 9.88 Mn |
| Jun 30, 2024 | 9.44 Mn |
| Mar 31, 2024 | 9.60 Mn |
| Dec 31, 2023 | 8.34 Mn |
| Sep 30, 2023 | 10.22 Mn |
| Jun 30, 2023 | 10.50 Mn |
| Mar 31, 2023 | 11.21 Mn |
| Dec 31, 2022 | 9.41 Mn |
| Sep 30, 2022 | 10.25 Mn |
| Jun 30, 2022 | 10.34 Mn |
| Mar 31, 2022 | 10.80 Mn |
| Dec 31, 2021 | 9.16 Mn |
API Access
Regenxbio Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();